Health IT Analytics January 22, 2018
Conducting genetic testing on the general populations proved more cost effective than testing only high-risk populations and may have long-term benefits for population health.
Screening the general population for breast and ovarian cancer gene mutations through genetic testing is more cost effective than screening only high-risk patients and may improve population health, according to a study published in the Journal of the National Cancer Institute.
Researchers measured the effects of screening American women aged 30 and older who had elevated risks for ovarian and breast cancer, and compared their results to the costs and effects of screening all women for these types of cancer.
Researchers developed a decision-analytic model to quantify costs, life expectancy, and quality-adjusted life-years (QALY), which reflect...
Today's Sponsors
Today's Sponsor